Structural basis of the interactions between CXCR4 and CXCL12/SDF-1 revealed by theoretical approaches.

The G protein-coupled chemokine receptor CXCR4 is implicated in a variety of physiological responses that also share several downstream effectors involved in multiple pathological processes. The interaction between CXCR4 and its natural ligand CXCL12/stromal-derived factor-1 (SDF-1) plays important roles in cancer metastasis, HIV-1 infection, and inflammatory diseases. Therefore, investigating the CXCR4-CXCL12 interaction is critical for understanding the molecular mechanisms of the modulation of chemokine-receptor functions and designing new pharmaceutical agents to target the CXCR4-CXCL12 pathway. Based on known experimental data, the interaction between CXCR4 and CXCL12 was predicted by an integrated protocol, which combines protein-protein docking, molecular dynamics (MD) simulations, Molecular Mechanics/Generalized Born Surface Area (MM/GBSA) binding free energy calculations, and MM/GBSA binding free energy decomposition analysis. The predicted CXCR4-CXCL12 binding pattern is in good agreement with the experimental data. Analysis of the binding structure reveals an obvious electrostatic complementarity between CXCR4 and CXCL12. Moreover, significant conformational rearrangements were observed during the 50 ns MD simulations. In particular, the basic Lys1 at the CXCL12 N-terminus, an essential residue in receptor activation, forms a strong polar interaction with the Glu32 in the CXCR4 extracellular region. It facilitates the significant movement of TM5 and TM6 in the conformational transition, which is coupled to the association with the intracellular signal transduction pathways via heterotrimer G-protein. Based on the dynamic and energetic analyses, a two-site binding model was proposed. We believe that our study provides useful information for understanding the mechanisms of CXCR4 ligand binding and structure-based drug design of CXCR4.

[1]  K. Matsushima,et al.  International union of pharmacology. XXII. Nomenclature for chemokine receptors. , 2000, Pharmacological reviews.

[2]  William A. McLaughlin,et al.  Evaluating the potency of HIV‐1 protease drugs to combat resistance , 2008, Proteins.

[3]  Tingjun Hou,et al.  Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: mechanism for binding and drug resistance. , 2007, Journal of medicinal chemistry.

[4]  Hideo Takahashi,et al.  Structural Basis of the Interaction between Chemokine Stromal Cell-derived Factor-1/CXCL12 and Its G-protein-coupled Receptor CXCR4* , 2009, The Journal of Biological Chemistry.

[5]  Christoph Seibert,et al.  Structural Basis of CXCR4 Sulfotyrosine Recognition by the Chemokine SDF-1/CXCL12 , 2008, Science Signaling.

[6]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[7]  J. Farber,et al.  Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.

[8]  Z. Weng,et al.  ZDOCK: An initial‐stage protein‐docking algorithm , 2003, Proteins.

[9]  Elias Lolis,et al.  Structural and Functional Basis of CXCL12 (Stromal Cell-derived Factor-1α) Binding to Heparin* , 2007, Journal of Biological Chemistry.

[10]  Wei Zhang,et al.  Characterization of Domain-Peptide Interaction Interface , 2009, Molecular & Cellular Proteomics.

[11]  Oliver P. Ernst,et al.  Crystal structure of opsin in its G-protein-interacting conformation , 2008, Nature.

[12]  Zhiping Weng,et al.  ZRANK: Reranking protein docking predictions with an optimized energy function , 2007, Proteins.

[13]  Lingling Shen,et al.  Molecular Dynamics Simulations on SDF-1α: Binding with CXCR4 Receptor , 2003 .

[14]  P. Scheerer,et al.  A G protein-coupled receptor at work: the rhodopsin model. , 2009, Trends in biochemical sciences.

[15]  Huanxiang Liu,et al.  Molecular modeling study on the resistance mechanism of HCV NS3/4A serine protease mutants R155K, A156V and D168A to TMC435. , 2012, Antiviral research.

[16]  Marlene Wolf,et al.  Chemokines: multiple levels of leukocyte migration control. , 2004, Trends in immunology.

[17]  B. Rollins,et al.  Chemokines and disease , 2001, Nature Immunology.

[18]  Ying Li,et al.  Crystal Structure and Structural Mechanism of a Novel Anti-Human Immunodeficiency Virus and d-Amino Acid-Containing Chemokine , 2007, Journal of Virology.

[19]  D. Case,et al.  Exploring protein native states and large‐scale conformational changes with a modified generalized born model , 2004, Proteins.

[20]  Lin Li,et al.  Understanding microscopic binding of macrophage migration inhibitory factor with phenolic hydrazones by molecular docking, molecular dynamics simulations and free energy calculations. , 2012, Molecular bioSystems.

[21]  Xiaojie Xu,et al.  Recent Advances in Free Energy Calculations with a Combination of Molecular Mechanics and Continuum Models , 2006 .

[22]  Wei Zhang,et al.  Predicting drug resistance of the HIV‐1 protease using molecular interaction energy components , 2009, Proteins.

[23]  Zhiping Weng,et al.  Docking unbound proteins using shape complementarity, desolvation, and electrostatics , 2002, Proteins.

[24]  Tingjun Hou,et al.  Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking , 2011, J. Comput. Chem..

[25]  P. Kollman,et al.  Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. , 2000, Accounts of chemical research.

[26]  Tingjun Hou,et al.  Studies on the Interactions between β2 Adrenergic Receptor and Gs Protein by Molecular Dynamics Simulations , 2012, J. Chem. Inf. Model..

[27]  M. Baggiolini.  Chemokines and leukocyte traffic , 1998, Nature.

[28]  I. D. de Esch,et al.  C(X)CR in silico: Computer-aided prediction of chemokine receptor-ligand interactions. , 2012, Drug discovery today. Technologies.

[29]  Won-Tak Choi,et al.  Distinct Functional Sites for Human Immunodeficiency Virus Type 1 and Stromal Cell-Derived Factor 1α on CXCR4 Transmembrane Helical Domains , 2005, Journal of Virology.

[30]  Changill Ban,et al.  Crystal structure of recombinant human stromal cell‐derived factor‐1α , 2006, Proteins.

[31]  D. Case,et al.  Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain. , 2008, Journal of molecular biology.

[32]  Brian F. Volkman,et al.  Recognition of a CXCR4 Sulfotyrosine by the Chemokine Stromal Cell-derived Factor-1α (SDF-1α/CXCL12) , 2006 .

[33]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[34]  Lin Li,et al.  Theoretical Studies on the Susceptibility of Oseltamivir against Variants of 2009 A/H1N1 Influenza Neuraminidase , 2012, J. Chem. Inf. Model..

[35]  Huanxiang Liu,et al.  In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase. , 2010, Molecular pharmaceutics.

[36]  B. Volkman,et al.  Structural determinants involved in the regulation of CXCL14/BRAK expression by the 26 S proteasome. , 2006, Journal of molecular biology.

[37]  Wei Wang,et al.  Characterization of domain-peptide interaction interface: prediction of SH3 domain-mediated protein-protein interaction network in yeast by generic structure-based models. , 2012, Journal of proteome research.

[38]  Li Li,et al.  RDOCK: Refinement of rigid‐body protein docking predictions , 2003, Proteins.

[39]  Alnawaz Rehemtulla,et al.  CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature , 2007, Proceedings of the National Academy of Sciences.

[40]  Oliver Beckstein,et al.  Lipidbook: A Public Repository for Force-Field Parameters Used in Membrane Simulations , 2010, The Journal of Membrane Biology.

[41]  M. Farzan,et al.  The Role of Post-translational Modifications of the CXCR4 Amino Terminus in Stromal-derived Factor 1α Association and HIV-1 Entry* , 2002, The Journal of Biological Chemistry.

[42]  Amy M. Fulton,et al.  The chemokine receptors CXCR4 and CXCR3 in cancer , 2009, Current oncology reports.

[43]  Martin Zacharias,et al.  Accounting for conformational changes during protein-protein docking. , 2010, Current opinion in structural biology.

[44]  W. C. Still,et al.  Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO) , 1999 .

[45]  Laxmikant V. Kalé,et al.  Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..

[46]  Beverly A. Teicher,et al.  CXCL12 (SDF-1)/CXCR4 Pathway in Cancer , 2010, Clinical Cancer Research.

[47]  V. Hornak,et al.  Comparison of multiple Amber force fields and development of improved protein backbone parameters , 2006, Proteins.

[48]  Tingjun Hou,et al.  Structural Bioinformatics Prediction of Peptides Binding to the Pka Riiα Subunit Using a Hierarchical Strategy , 2022 .

[49]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[50]  Paul E. Kennedy,et al.  HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.

[51]  N Nandhagopal,et al.  Crystal structure of recombinant native SDF-1alpha with additional mutagenesis studies: an attempt at a more comprehensive interpretation of accumulated structure-activity relationship data. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[52]  R. Abagyan,et al.  Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.

[53]  Huanxiang Liu,et al.  Understanding the effect of drug-resistant mutations of HIV-1 intasome on raltegravir action through molecular modeling study. , 2012, Molecular bioSystems.

[54]  Piotr Cieplak,et al.  Molecular dynamics and free energy analyses of cathepsin D-inhibitor interactions: insight into structure-based ligand design. , 2002, Journal of medicinal chemistry.

[55]  D. Case,et al.  Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes. , 2003, Journal of molecular biology.

[56]  Tingjun Hou,et al.  Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations , 2011, J. Chem. Inf. Model..

[57]  Cimona V Hinton,et al.  Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain , 2010, Clinical & Experimental Metastasis.

[58]  Zhaowen Luo,et al.  Structural and Functional Characterization of Human CXCR4 as a Chemokine Receptor and HIV-1 Co-receptor by Mutagenesis and Molecular Modeling Studies* , 2001, The Journal of Biological Chemistry.

[59]  J. Inazawa,et al.  Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. , 1995, Genomics.

[60]  C. Tate,et al.  Agonist-bound structures of G protein-coupled receptors. , 2012, Current opinion in structural biology.

[61]  B. Sykes,et al.  Solution structure and basis for functional activity of stromal cell‐derived factor‐1; dissociation of CXCR4 activation from binding and inhibition of HIV‐1 , 1997, The EMBO journal.

[62]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .